Trial Profile

Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation - SToP-CAV

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 16 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atorvastatin (Primary)
Indications Coronary artery disease
Focus Therapeutic Use
Acronyms StatinCAV; SToP-CAV

Most Recent Events

13 Jan 2025 Status changed from not yet recruiting to withdrawn prior to enrolment, as study was never submitted. Study team instead conducted a retrospective study which did not qualify for registration.
08 Dec 2023 Planned initiation date changed from 1 Jan 2024 to 1 Jan 2025.
05 Jan 2023 Planned End Date changed from 1 Jun 2026 to 1 Jun 2030.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com